Fred Dorey is a special counsel in the Life Sciences practice group of the Cooley Business department and is active in the Clean Technologies practice group. He joined the Firm in 1997 and is resident in both the Palo Alto and San Francisco offices.
Mr. Dorey represents a range of biotechnology, instrumentation and other technology companies at various stages of development from start-up and incorporation through licensing, corporate partnering and major collaboration transactions. He also has extensive experience negotiating clinical trial, sponsored research and intellectual property agreements.
In addition, Mr. Dorey advises a number of major foundations, research institutions, and individuals regarding their participation in biomedical research endeavors, including investment, licensing and commercialization activities.
Before joining the Firm, Mr. Dorey was the first president of the Bay Area Bioscience Center, a consortium of research universities, biotechnology companies and local governments organized to support bioscience development in Northern California. He also served as part-time in house counsel for several biotech companies including Tularik, Geron and Shaman. Previously, he had served as general counsel and corporate secretary for British Petroleum in San Francisco, where he was chief legal advisor for the Fortune 500-sized subsidiary that handled all BP oil exploration and production in the United States.
He has also served as a regulatory enforcement lawyer and assistant office director for the Department of Energy in Washington DC.
Mr. Dorey received a JD from the University of Southern California Law Center, where he was president of the Student Bar Association. Before law school he served as a White House Intern in the office of the Director of the Peace Corps in Washington DC. He received a BS in Engineering from University of California, Los Angeles.
Mr. Dorey currently serves as a director of the BayBio Institute and the National Board of Community Health Charities. He is a member of the President's Council of the Gladstone Institutes and is active with the American Liver Foundation.
